Senate Bill 4132
116th Congress(2019-2020)
National Commission on the COVID–19 Pandemic in the United States Act
Introduced
Introduced
Introduced in Senate on Jul 1, 2020
Overview
Text
Introduced
Jul 1, 2020
Latest Action
Jul 1, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4132
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
California
Wisconsin
Delaware
Maryland
Massachusetts
California
Minnesota
Minnesota
Pennsylvania
Rhode Island
Massachusetts
No Senate votes have been held for this bill.
Summary

National Commission on the COVID-19 Pandemic in the United States Act

This bill establishes, in the legislative branch, the National Commission on the COVID-19 Pandemic in the United States and sets forth its powers, duties, funding, and membership. Among other activities, the commission shall investigate the facts and circumstances of the COVID-19 (i.e., coronavirus disease 2019) pandemic and make recommendations on preventing a similar outbreak from occurring in the future.

The commission terminates 60 days after the submission of its final report.

Text (1)
Actions (2)
07/01/2020
Read twice and referred to the Committee on Rules and Administration. (Sponsor introductory remarks on measure: CR S4138-4139)
07/01/2020
Introduced in Senate
Public Record
Created
Jul 2, 2020 5:42:10 AM
Updated
Dec 28, 2020 8:15:57 PM